RAPT THERAPEUTICS INC (RAPT)

US75382E1091 - Common Stock

8.33  +0.21 (+2.52%)

After market: 8.33 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.001.53M3.81M5.04M0.00
Operating Expenses
127.06M87.32M73.02M58.26M43.63M
Research and Development
101.00M67.08M56.99M45.49M34.91M
Selling, General, and Administrative Expenses
26.06M20.24M16.04M12.77M8.72M
Operating Income
-127.06M-85.80M-69.21M-53.21M-43.63M
Other Income/Expense
10.26M1.96M10.00K1.31M1.29M
Income Before Taxes
-116.80M-83.84M-69.20M-51.90M-42.34M
Income Tax
N/AN/A0.00990.00K660.00K
Net Income
-116.80M-83.84M-69.20M-52.89M-43.00M
EBITDA
-125.85M-84.75M-68.21M-52.09M-42.30M
 
Per Share Data
EPS Diluted Total Ops
-3.05-2.58-2.53-2.19-1.89
Non GAAP EPS
-3.04-2.58-2.53-2.19N/A
 
Statistics
Profit Margin
N/A-5479.74%-1816.27%-1049.40%N/A
Operating Profit Margin
N/A-5607.84%-1816.54%-1055.75%N/A

All data in USD

Charts